Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-20-001806

CEO acquired 262,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Woods Lori A CEO 2020-02-03 Option exercise +75,000 $0.61 $45,375 355,000 I: show line 1 in the form
Woods Lori A CEO 2020-02-03 Option exercise +125,000 $0.46 $57,500 480,000 I: show line 2 in the form
Woods Lori A CEO 2020-02-03 Option exercise +62,500 $0.43 $26,875 542,500 I: show line 3 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Woods Lori A CEO 2020-02-03 Option exercise · Stock Options (right to buy) −75,000 25,000 D: show line 4 in the form
Woods Lori A CEO 2020-02-03 Option exercise · Stock Options (right to buy) −125,000 125,000 D: show line 5 in the form
Woods Lori A CEO 2020-02-03 Option exercise · Stock Options (right to buy) −62,500 187,500 D: show line 6 in the form
Loading xslF345X03/rdgdoc.xml…